FSTL3 and Hepatic fibrosis: Lastly, the mediating effect of serum follistatin-like protein 3 (FSTL3) is found to be associated with increased liver fibrosis risk in patients with MI and T2D (n = 1,424), using the Gene Expression Omnibus (GEO) analysis.